Press Releases
Philogen announces new publication in Nature Chemistry
The study was conducted by scientists at Philochem AG, the wholly owned Swiss subsidiary company of the Philogen group. The paper can be accessed on the Nature Chemistry website at...
Read morePhilochem will be attending the 10th World ADC Conference in London
Philochem will be attending the 10th World ADC Conference in London (United Kingdom) from March 2 to 5, 2020 10th World ADC London Dr. Samuele Cazzamalli will give a plenary lecture on: “Small...
Read morePhilogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands
Philogen announces publication in Chem (Cell Press) on novel affinity matured OncoFAP ligands isolated from DNA-Encoded Chemical Libraries. The novel OncoFAP ligands show a prolonged residence time in Fibroblast Activation Protein (FAP)...
Read morePhilogen publishes a new study on OncoFAP in Clinical Cancer Research
The study shows excellent tumor uptake of the novel OncoFAP-MMAE Small Molecule-Drug Conjugates (SMDCs) with high and selective release of the cytotoxic MMAE payload at the tumor site. OncoFAP-based pro-drugs...
Read morePhilogen announces publication of IL12-7NP2 (an Interleukin-12 fusion protein against Fibroblast Activation Protein) in Journal for Immunotherapy of Cancer.
The study shows selective tumor uptake of IL12-7NP2 and potent antitumor activity as single agent and in combination with immune checkpoint inhibitors. The product is well tolerated when administered to...
Read moreUpcoming Events
Philogen to attend the TIDES Europe 2022 in Vienna, Austria (16-18 November)
Philogen will attend the TIDES Europe in Vienna in November 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture entitled “Non-internalizing Small Molecule-Drug Conjugates and...
Read morePhilogen to attend the PEGS Europe 2022 on November 14-16, 2022
Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Antibody-cytokine fusions: emerging clinical data in glioblastoma, sarcoma and dermato-oncology indications”. Please follow the link below for more information...
Read morePast Events
Philochem to attend the 71st American Society for Mass Spectrometry Conference on June 4-8, 2023
Dr. Ettore Gilardoni (Head of Bio-MS) will present a poster entitled: Proteomic analysis reveals insights into the mechanism of the Intra-cork approach for increasing therapeutic window of immunocytokines Domenico Ravazza,...
Read morePhilogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Sara Puglioli. Matilde Bocci, Giulia Rotta, Eleonora Prodi and...
Read morePhilogen to attend Mid & Small | London 2023 Conference on April 20, 2023
Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event to present Philogen and its programs to the financial community.